электронные сигареты атомайзеры

Study: Biotech no riskier for investors


Despite lower sales, lack of profits and heavy R&D spending, biotech companies that went public between 1997 and 2016 reached similar market caps as non-biotech companies, according to an academic study.

[fixed][/fixed]
[poll] {poll} [/poll]
Marijuana deliveri